Key result
A diabetes duration of ≥10 years was associated with a significantly higher proportion of IVUS-defined thin-cap fibroatheroma compared to <10 years (54.4% vs 10.8%; P=0.009).
Why the study?
Does longer diabetes duration (≥ 10 years) increase the proportion of thin-cap fibroatheroma detected by IVUS compared to shorter duration (< 10 years) in diabetic patients undergoing coronary angiography?
Observational (n=54)
Does longer diabetes duration (≥ 10 years) increase the proportion of thin-cap fibroatheroma detected by IVUS compared to shorter duration (< 10 years) in diabetic patients undergoing coronary angiography?
Absolute Event Rate: 54.4% vs 10.8%
p-value: p=0.009
Longer duration of diabetes (≥ 10 years) is associated with increased high-risk plaque features (TCFA) and greater plaque burden on IVUS, suggesting a mechanism for increased coronary risk over time in diabetic patients.
Diabetes duration ≥10 years may flag higher-risk plaques on IVUS; hypothesis-generating for duration-based risk stratification in diabetic CAD.
BACKGROUND: Coronary plaque classified as thin-cap fibroatheroma (TCFA) is believed to be associated with plaque rupture and coronary heart disease-related events. Although an association between duration of diabetes and increased coronary heart disease risk has been demonstrated, the relationship between TCFA and diabetes duration is unknown. METHODS AND RESULTS: Prospective registry of diabetic patients undergoing diagnostic coronary angiography and intravascular ultrasound (IVUS) enrolled in a diabetic gene and biomarker banking registry. Plaque composition in the most diseased 10-mm segment of a single coronary artery was assessed using IVUS virtual histology and was classified by phenotype as IVUS-defined adaptive intimal thickening, pathological intimal thickening, TCFA, fibroatheroma, or fibrocalcific. Patients (n=54) were stratified by duration of diabetes (<10 or > or = 10 years). Patients with diabetes > or = 10 years were older, less likely to have a history of tobacco use, had higher total cholesterol levels, and were more likely to be treated with insulin compared with patients with diabetes <10 years. Longer duration of diabetes was associated with greater plaque burden in the most diseased 10-mm segment (60.4% [53.4% to 66.8%] versus 50.2% [47.7% to 58.4%], P=0.008). The proportion of IVUS-defined TCFA in the > or = 10-year group was greater than the <10-year group (54.4% [11.6% to 77.5%] versus 10.8% [0.0% to 26.1%], P=0.009). This association persisted after adjustment for multiple comparisons, clinical characteristics, and diabetes treatment. CONCLUSIONS: In this cohort, longer duration of diabetes was associated with IVUS-defined TCFA, a plaque phenotype associated with risk of rupture and coronary heart disease events. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00428961.
No takes yet. Share an insight, caveat, or question.
Lindsey et al. (2009) conducted an observational in Diabetes mellitus with coronary artery disease (n=54). Diabetes duration ≥10 years vs. Diabetes duration <10 years was evaluated on Proportion of IVUS-defined thin-cap fibroatheroma (TCFA) (p=0.009). A diabetes duration of ≥10 years was associated with a significantly higher proportion of IVUS-defined thin-cap fibroatheroma compared to <10 years (54.4% vs 10.8%; P=0.009).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: